Kaneb Hannah M, Folkmann Andrew W, Belzil Véronique V, Jao Li-En, Leblond Claire S, Girard Simon L, Daoud Hussein, Noreau Anne, Rochefort Daniel, Hince Pascale, Szuto Anna, Levert Annie, Vidal Sabrina, André-Guimont Catherine, Camu William, Bouchard Jean-Pierre, Dupré Nicolas, Rouleau Guy A, Wente Susan R, Dion Patrick A
Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada H3A 2B4, Department of Neurology and Neurosurgery, McGill University, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada H2L 2W5.
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Hum Mol Genet. 2015 Mar 1;24(5):1363-73. doi: 10.1093/hmg/ddu545. Epub 2014 Oct 24.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective death of motor neurons. Causative mutations in the global RNA-processing proteins TDP-43 and FUS among others, as well as their aggregation in ALS patients, have identified defects in RNA metabolism as an important feature in this disease. Lethal congenital contracture syndrome 1 and lethal arthrogryposis with anterior horn cell disease are autosomal recessive fetal motor neuron diseases that are caused by mutations in another global RNA-processing protein, hGle1. In this study, we carried out the first screening of GLE1 in ALS patients (173 familial and 760 sporadic) and identified 2 deleterious mutations (1 splice site and 1 nonsense mutation) and 1 missense mutation. Functional analysis of the deleterious mutants revealed them to be unable to rescue motor neuron pathology in zebrafish morphants lacking Gle1. Furthermore, in HeLa cells, both mutations caused a depletion of hGle1 at the nuclear pore where it carries out an essential role in nuclear export of mRNA. These results suggest a haploinsufficiency mechanism and point to a causative role for GLE1 mutations in ALS patients. This further supports the involvement of global defects in RNA metabolism in ALS.
肌萎缩侧索硬化症(ALS)是一种致命的神经退行性疾病,其特征是运动神经元选择性死亡。全球RNA加工蛋白TDP - 43和FUS等的致病突变,以及它们在ALS患者中的聚集,已确定RNA代谢缺陷是该疾病的一个重要特征。致死性先天性挛缩综合征1和伴有前角细胞疾病的致死性关节挛缩是常染色体隐性遗传性胎儿运动神经元疾病,由另一种全球RNA加工蛋白hGle1的突变引起。在本研究中,我们首次对ALS患者(173例家族性和760例散发性)进行了GLE1筛查,鉴定出2个有害突变(1个剪接位点突变和1个无义突变)和1个错义突变。对有害突变体的功能分析表明,它们无法挽救缺乏Gle1的斑马鱼胚胎中的运动神经元病理。此外,在HeLa细胞中,这两种突变均导致hGle1在核孔处耗竭,而hGle1在mRNA核输出中发挥重要作用。这些结果提示了一种单倍剂量不足机制,并指出GLE1突变在ALS患者中具有致病作用。这进一步支持了RNA代谢的整体缺陷与ALS有关。